GLP-1 therapies show potential for treating rare genetic disorder Bardet-Biedl syndrome

A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for individuals living with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments.

Leave A Comment

Your email address will not be published. Required fields are marked *